Finasteride and Tamsulosin Hydrochloride Extended-Release Capsules can be used in the treatment of prostate enlargement, but the two drugs have different principles of action, different adverse reactions, and the therapeutic effect of the drugs are different, there is no so-called “which one is better”, it should be selected by the doctor according to the patient’s condition, physical condition of the patient’s treatment of the appropriate drugs. Finasteride is a 5α-reductase inhibitor, which can inhibit the conversion of peripheral testosterone into dihydrotestosterone, thus inhibiting prostate hyperplasia and improving the clinical symptoms of BPH, therefore, Finasteride can be used to treat symptomatic BPH. Finasteride is well tolerated, a few patients may experience adverse reactions such as rash and breast discomfort, and the symptoms are generally mild and transient. Tamsulosin Hydrochloride Extended-Release Capsules is an α1-adrenoceptor blocker, which improves symptoms such as difficulty in urination due to benign prostatic hyperplasia by relaxing the smooth muscle of the prostate. Patients may experience disorientation, loss of consciousness, and may also experience dizziness, palpitations, nausea and vomiting, abdominal pain, and other discomforts while on the medication. Finasteride and Tamsulosin Hydrochloride Extended-Release Capsules are both prescription medications. Patients with prostate enlargement should consult a doctor in a timely manner and use the appropriate medication under the doctor’s guidance, and should not blindly use the medication on their own in order to avoid ineffective treatment or serious adverse effects.